Vinay Prasad's acting replacement, remembering genomics pioneer J. Craig Venter, and more biotech news from The Readout ...
The FDA proposed excluding the active ingredients in popular obesity and diabetes drugs from a list of substances that can be ...
FDA review confirmed overall safety of 16 brands of baby formula. In a STAT Q&A, experts unpack what low-level PFAS findings ...
J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...
Efforts to make customized medicines at scale have hit commercial and regulatory roadblocks. Julia Vintarello is trying again ...
At the hearing, the judge heard from mothers who lost sons to overdose, a teenager born into withdrawal, and people who spent ...
Most of the infant formula in the U.S. is safe, but experts and health officials say regulators can take steps to make the ...
Psychedelics’ potential as a form of treatment is virtually unmatched. But their promise faces both scientific uncertainty ...
America is worried about fertility rates — again. Coverage of the country’s declining birth rate reflects widespread unease: ...
Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.
Elevance Health is blocking the deposition of Peter Haytaian, an outgoing executive who previously oversaw the health insurer ...
Imagine standing on a vast, dark plain. Without light, you cannot see dips and rolls in the grass or make out hills and valleys. Even if there’s a city off in the distance to your right, it does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results